Analysis of serological findings and clinical manifestations of TORCH infections in newborns.
- Author:
Lei WANG
1
;
Ke-hua LI
;
Hong LIU
;
Jing-yuan LIU
;
Yun-juan LI
Author Information
- Publication Type:Journal Article
- MeSH: Antibodies, Viral; blood; immunology; Cytomegalovirus Infections; immunology; Female; Herpes Simplex; immunology; Humans; Infant, Newborn; Infant, Newborn, Diseases; immunology; virology; Male; Neonatal Screening; Retrospective Studies; Rubella; immunology; Toxoplasmosis; immunology
- From: Chinese Journal of Experimental and Clinical Virology 2003;17(3):283-284
- CountryChina
- Language:Chinese
-
Abstract:
BACKGROUNDTo search for the serological findings and early clinical manifestations as evidences for prevention and treatment TORCH infections in pregnant women and newborns as early as possible.
METHODSELASA was performed to screen specific anti-TORCH (Toxoplasma gondii, Cytomegalovirus, Rubella virus, Herpes simplex virus) Ig-M antibodies.
RESULTSTotally 1,554 in-patients who were treated in Neonatal Intensive Care Unit (NICU) of our hospital from January 2000 to January 2003 were retrospectively studied, 48 of them had TORCH infections. Cytomegalovirus (CMV), rubella and herpes simplex virus infections accounted for 52.1%, 33.3% and 14.6%, respectively. None of them had toxoplasma infection.
CONCLUSIONTORCH infections can cause multiorgan lesions, such as hearing impairment, hyperbilirubinemias and liver dysfunction, impairment of neurologic system, myocardial impairment, thrombocytopenia, and congenital heart disease.Rubella vaccine inoculation, serological screening during pregnancy and early period of newborn, intervention and treatment in the early period are most important.
